3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine

  title={3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine},
  author={Dennis J. Mckenna and Xiao-ming Guan and Alexander T. Shulgin},
  journal={Pharmacology Biochemistry and Behavior},

Figures and Tables from this paper

Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats
Analysis of concurrent single-unit activity and behavior confirmed that MDMA-induced striatal activation was not merely due to behavioral feedback, indicating a primary action of MDMA.
Comparative behavioural and neurochemical studies with a psychomotor stimulant, an hallucinogen and 3,4-methylenedioxy analogues of amphetamine
Both the neurochemical and the behavioural measures supported the existence of an entactogen class distinct from a psychomotor stimulant and an hallucinogen.
Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices
The effects of methylenedioxymethamphetamine (MDMA) and amphetamine on monoamine release from rat superfused brain slices in both the presence and absence of vesicular stores of transmitter are investigated.
The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA).
The pharmacodynamics and kinetics of 3,4-methylenedioxy-N-ethylamphetamine are described on the basis of MDEA challenge studies in animals and humans and a collection of case reports on fatalities where MDEa was toxicologically confirmed are presented.
Synthesis and pharmacological evaluation of ring-methylated derivatives of 3,4-(methylenedioxy)amphetamine (MDA).
Two isomeric ring-methylated derivatives of the well-known hallucinogen and entactogen MDA were synthesized and evaluated for pharmacological activity as monoamine-releasing agents and as serotonin agonists and found to be more potent and more selective in inhibiting [3H]-serotonin accumulation in rat brain synaptosomal preparations.


Effects of certain hallucinogenic amphetamine analogues on the release of [3H]serotonin from rat brain synaptosomes.
The enantiomers of 3,4-(methylenedioxy)amphetamine (MDA), p-methoxyamphetamine (PMA), and N-Me-MDA (MDMA), along with their alpha, alpha-dimethylated derivatives, were evaluated for an effect on the release of [3H]serotonin from rat whole brain synaptosomes and suggested that transmitter release may play a role in the biological activity of MDMA.
Acute administration of methylenedioxymethamphetamine: comparison with the neurochemical effects of its N-desmethyl and N-ethyl analogs.
  • C. J. Schmidt
  • Chemistry, Biology
    European journal of pharmacology
  • 1987
Ring-substituted amphetamine interactions with neurotransmitter receptor binding sites in human cortex
Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.
LSD partially antagonized the effect of 5-HT in the choroid plexus, consistent with a partial agonist effect at the 5- HT-1c receptor in this tissue.
Antagonism of 5-hydroxytryptamine2 receptor-mediated phosphatidylinositol turnover by d-lysergic acid diethylamide.
  • P. Pierce, S. Peroutka
  • Biology, Chemistry
    The Journal of pharmacology and experimental therapeutics
  • 1988
The interactions of the indolealkylamine hallucinogen d-lysergic acid diethylamide (d-LSD) and two phenalkylamine hallucinogens, 2,5-dimethoxy-4-bromoamphetamine (DOB) and